| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001003669A3 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 07/12/2001 | WO2000076500A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 07/12/2001 | WO2000072799A3 Method and compositions for treating the inflammatory response |
| 07/12/2001 | WO2000061230A3 Estrogen receptors-beta antagonism and bone diseases |
| 07/12/2001 | WO2000059490A8 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000051589A3 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010007902 An oligonucleotide complementary to a region of the ribonucleotide component of telomerase attached to an activator of ribonuclease L (activator-antisense complex) which cleaves ribonuclotide portion of telomerase enzyme |
| 07/12/2001 | US20010007853 By inhalation |
| 07/12/2001 | US20010007745 Genetic engineering |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007670 Novel formulations comprising lipid-regulating agents |
| 07/12/2001 | US20010007663 Microemulsions for use as vehicles for administration of active compounds |
| 07/12/2001 | US20010007651 Masking and eliminating odors; preservative, counterirritant, solubility enhancer, antiseptic, fungicide, microbiocide, anti-infective, healing agent; smoker's-breath; placebo |
| 07/12/2001 | DE19962998A1 New integrin receptor ligands, especially integrin-alphavbeta3 ligands, useful for treating e.g. atherosclerosis, rheumatoid arthritis, restenosis, angioplasty and acute kidney failure |
| 07/12/2001 | DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents |
| 07/12/2001 | CA2475413A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2475393A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2396234A1 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | CA2395955A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395695A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/12/2001 | CA2395606A1 Novel indole derivatives |
| 07/12/2001 | CA2395487A1 Composition for the treatment of damaged tissue |
| 07/12/2001 | CA2394721A1 Product for treating gynecomastia |
| 07/12/2001 | CA2362453A1 Treatment of acne using lipoic acid |
| 07/12/2001 | CA2328634A1 Assay method |
| 07/11/2001 | EP1114644A1 Composition comprising NPH insulin (neutral protamine hagedorn insulin) |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114182A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114144A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114032A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1114031A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1113811A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/11/2001 | EP1113809A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 07/11/2001 | EP1113801A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP1113792A1 A new composition |
| 07/11/2001 | EP0799615B1 Liposome eye drops |
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303381A Dipeptidyl peptidase IV effectors |
| 07/11/2001 | CN1303380A Isothizole derivatives useful anticancer agents |
| 07/11/2001 | CN1303302A Minoxidil compositions for external use |
| 07/11/2001 | CN1303297A Treatment of arthritis and other similar conditions |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1303287A Opioid agonist/antagonist combinations |
| 07/11/2001 | CN1303286A Use of cabergoline in treatment of restless legs syndrome |
| 07/11/2001 | CN1303282A Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1302608A Clonidine preparation |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/11/2001 | CN1068228C Medicine for reducing pathologic raised beta-receptor and its producing technology |
| 07/10/2001 | US6258932 Tripeptide of defined amino acid sequence and having a c-terminal amide; viricides; treatment and prevention of human immunodeficiency virus |
| 07/10/2001 | US6258846 Enriching breast milk |
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258828 Chelating agents and their metal chelates for treating free radical induced conditions |
| 07/10/2001 | US6258827 Combinations for the treatment of parkinsonism containing selective NMDA antagonists |
| 07/10/2001 | US6258811 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (GVHD) and organ transplantation |
| 07/10/2001 | US6258802 Corticoid therapy |
| 07/10/2001 | US6258795 Compounds for treatment of diabetes, cardiovascular disorders, nervous system disorders and respiratory system disorders |
| 07/10/2001 | US6258791 Enhanced delivery of nucleic acid into humans or animals |
| 07/10/2001 | US6258780 Method and composition for enabling passage through the blood-brain-barrier |
| 07/10/2001 | US6258774 Carrier for in vivo delivery of a therapeutic agent |
| 07/10/2001 | US6258598 EBV-infected stomach cancer cell line |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258532 Evaluating sensitivity of microorganism to test substance; incubate microorganism with test substance, screen for microorganism sequences, absence of microorganismal nucleotide sequences indicates sensitivity to test substance |
| 07/10/2001 | US6258379 Kit with container including indicia and instructions for concurrent diuretic administration |
| 07/10/2001 | US6258378 Delivery of biologically active substance to target sites in the body of patients |
| 07/10/2001 | US6258376 Treating helicobacter infections and gastrointestinal disorders; antiulcer agents |
| 07/10/2001 | US6258374 Rectal or vaginal administration; polymer stabilizer; water soluble foam structure |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/05/2001 | WO2001048483A2 Method for screening of appetite control agents |
| 07/05/2001 | WO2001048238A2 Chemotherapeutant screening method |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048171A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT Cβ OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 07/05/2001 | WO2001048020A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |